These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6679152)

  • 21. Differential agar medium (A7) for identification of Ureaplasma urealyticum (human T mycoplasmas) in primary cultures of clinical material.
    Shepard MC; Lunceford CD
    J Clin Microbiol; 1976 Jun; 3(6):613-25. PubMed ID: 950379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experiences with oxytetracycline treatment of non-gonorrhea urethritis caused by Ureaplasma urealyticum].
    Elsner P; Hartmann AA; Burg G
    Hautarzt; 1990 Feb; 41(2):94-7. PubMed ID: 2318645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrolysis of urea by Ureaplasma urealyticum generates a transmembrane potential with resultant ATP synthesis.
    Smith DG; Russell WC; Ingledew WJ; Thirkell D
    J Bacteriol; 1993 Jun; 175(11):3253-8. PubMed ID: 8501029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infection of the epididymis by Ureaplasma urealyticum.
    Jalil N; Doble A; Gilchrist C; Taylor-Robinson D
    Genitourin Med; 1988 Dec; 64(6):367-8. PubMed ID: 3224973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of Mycoplasma hominis and Ureaplasma urealyticum infection in pregnant women and gynaecological patients; the effectivity of doxycycline therapy.
    Horváth B; Turay A; Lakatos F; Végh G; Illei G
    Ther Hung; 1989; 37(1):23-7. PubMed ID: 2756511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flurofamide: a potent inhibitor of bacterial urease with potential clinical utility in the treatment of infection induced urinary stones.
    Millner OE; Andersen JA; Appler ME; Benjamin CE; Edwards JG; Humphrey DT; Shearer EM
    J Urol; 1982 Feb; 127(2):346-50. PubMed ID: 7038144
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-mycoplasmal activity of a new macrolide: miocamycin.
    Furneri PM; Tempera G; Bisignano G; Cottarelli FV; Nicoletti G
    Chemioterapia; 1987 Oct; 6(5):341-5. PubMed ID: 3501335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the distribution and characteristics of isozyme expression in Mycoplasma, Acholeplasma, and Ureaplasma species.
    O'Brien SJ; Simonson JM; Razin S; Barile MF
    Yale J Biol Med; 1983; 56(5-6):701-8. PubMed ID: 6679151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of anti-Ureaplasma urease antibody on homologous and heterologous urease activities.
    Eng H; Robertson JA; Stemke GW
    Microbios; 1987; 49(198):47-54. PubMed ID: 2436028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ammonium ion concentration and osmotic pressure on growth of Ureaplasma urealyticum (T-strain mycoplasma).
    Sayed IA; Kenny GE
    J Bacteriol; 1978 Jun; 134(3):967-72. PubMed ID: 26668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Rylander M; Hallander HO
    Scand J Infect Dis Suppl; 1988; 53():12-7. PubMed ID: 2843982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of Mycoplasma hominis and Ureaplasma urealyticum in patients with leukospermia].
    Schmidt U; Pfützner H; Hartmann M
    Arch Exp Veterinarmed; 1989; 43(5):801-8. PubMed ID: 2619480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Urethrogenital disorders and Ureaplasma urealyticum. The necessity for an antibiogram].
    Claude JM; Marinelli G; Bonissol C
    Nouv Presse Med; 1981 Jan; 10(3):179. PubMed ID: 7220326
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ureaplasma urealyticum--a new problem pathogen in neonatology].
    Satow K; Groneck P; Schütt-Gerowitt H; Roth B; Benz-Bohm G
    Monatsschr Kinderheilkd; 1991 Jun; 139(6):344-8. PubMed ID: 1896046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colony morphology, ultrastructure and morphogenesis in Mycoplasma hominis, Acholeplasma laidlawii and Ureaplasma urealyticum.
    Meloni GA; Bertoloni G; Busolo F; Conventi L
    J Gen Microbiol; 1980 Feb; 116(2):435-43. PubMed ID: 7373281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of ofloxacin in the treatment of genitourinary tract infection with Ureaplasma urealyticum.
    Kawamura N; Nakajima N; Hoshino H; Tanaka M; Koinuma A
    Hinyokika Kiyo; 1989 Dec; 35(12):2149-53. PubMed ID: 2618914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mollicutes DNA polymerases: characterization of a single enzyme from Mycoplasma mycoides and Ureaplasma urealyticum and of three enzymes from Acholeplasma laidlawii.
    Maurel D; Charron A; Bébéar C
    Res Microbiol; 1989; 140(3):191-205. PubMed ID: 2694245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum infections in women. Prevalence, risks and management at a South African infertility clinic.
    Marais NF; Wessels PH; Smith MS; Gericke A; Richter A
    J Reprod Med; 1991 Mar; 36(3):161-4. PubMed ID: 2030488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycoplasma hominis and Ureaplasma urealyticum. Comparison of media for isolation and prevalence among patients with nongonococcal nonchlamydial genital infections.
    Cavicchini S; Biffi MR; Brezzi A; Alessi E
    G Ital Dermatol Venereol; 1989; 124(7-8):321-4. PubMed ID: 2628275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of genital Mycoplasma and Ureaplasma infections.
    Friberg J
    J Reprod Med; 1985 Mar; 30(3 Suppl):258-61. PubMed ID: 4020782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.